Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors

• প্রধান লেখক: Anthony T. P. Chan (লেখক), Sydney C. W. Tang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: The Korean Society of Nephrology, 2022-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Progress in the treatment of diabetic kidney disease (DKD) has been modest since the early trials on renin-angiotensin-aldosterone system inhibitors (RAASis). Although sodium-glucose co-transporter 2 inhibitors (SGLT2is) have revolutionized the management of DKD by lowering proteinuria and protectin...